Amniotic membrane after crosslinking for progressive keratoconus
Part of Eyes & vision clinical trials.
This trial tests if placing a special freeze-dried amniotic membrane on the eye after crosslinking surgery helps improve healing and comfort for people with progressive keratoconus, a condition where the cornea thins and bulges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have progressive keratoconus (vision getting worse over time).
- Your cornea is thick enough (more than 400 microns).
- You have not had crosslinking or certain eye surgeries before.
- You are not pregnant or breastfeeding, and use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how safe and effective corneal cross-linking is for people with keratoconus, a condition that changes the shape of the clear front surface of the eye. If you qualify, the study will also require several follow-up visits to check your eye health over time.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
This trial tests a new eyedrop (TN-001) for people with keratoconus that is getting worse. The drops are applied twice a day to try to stop the cornea from thinning and bulging further.
This Phase 1 study tests whether a specific corneal cross-linking system (called PXL-Platinum 330) is safe and effective for people with progressive keratoconus, a condition that makes the cornea thin and bulge. The goal is to slow vision changes and see how well the treatment works in the short term.
Hear when a new Progressive Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.